Boehringer Ingelheim develops breakthrough therapies that transform lives. As a leading research-driven biopharmaceutical company, it drives innovation in areas of high unmet medical need. Founded in 1885 and family-owned, it takes a long-term approach to Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. With over 52,000 employees serving 130+ markets, it remains committed to creating value through science and innovation.